An Academy discussion brought together leaders in clinical care, regulation, and industry to analyze and understand the impact of the administration's changes in vaccine policy. The panelists shared insights on the volatile situation, assessed the impact, and spoke about what can be done to protect the nation’s long-term capacity to develop, test, and deliver vaccines.